Richard A. Miller MD - 10 May 2024 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
President and CEO, Director
Signature
/s/ Richard A. Miller
Issuer symbol
CRVS
Transactions as of
10 May 2024
Net transactions value
$0
Form type
4
Filing time
14 May 2024, 17:02:49 UTC
Previous filing
07 May 2024
Next filing
23 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Gift $0 -302,016 -20% $0.000000 1,188,103 10 May 2024 By Trust F1
holding CRVS Common Stock 577,634 10 May 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.